As next-generation antibody-drug conjugates reshape cancer care, digital pathology and artificial intelligence are transforming how HER2 is measured. The advances aim to help clinicians identify low ...
First-of-its-kind digital pathology network powered by PathAI’s AISight® platform expands access to latest AI products, unlocks real-world data value, and fuels collaborative research with biopharma ...
Proscia, a leading provider of digital pathology software, released DermAI™, the first in its series of AI applications that advance the practice of pathology. A module on Proscia’s Concentriq™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results